Abstract:IntroductionThe concept of quality by design (QbD) has been widely accepted and applied in the pharmaceutical manufacturing industry. There are still two key issues to be addressed in the implementation of QbD for herbal drugs. The first issue is the quality variation of herbal raw materials and the second issue is the difficulty in defining the acceptable ranges of critical quality attributes (CQAs). ObjectiveTo propose a feedforward control strategy and a method for defining the acceptable ranges of CQAs for the two issues. MethodsIn the case study of the ethanol precipitation process of Danshen (Radix Salvia miltiorrhiza) injection, regression models linking input material attributes and process parameters to CQAs were built first and an optimisation model for calculating the best process parameters according to the input materials was established. Then, the feasible material space was defined and the acceptable ranges of CQAs for the previous process were determined. ResultsIn the case study, satisfactory regression models were built with cross-validated regression coefficients (Q(2)) all above 91 %. The feedforward control strategy was applied successfully to compensate the quality variation of the input materials, which was able to control the CQAs in the 90-110 % ranges of the desired values. In addition, the feasible material space for the ethanol precipitation process was built successfully, which showed the acceptable ranges of the CQAs for the concentration process. ConclusionThe proposed methodology can help to promote the implementation of QbD for herbal drugs. Copyright (c) 2013 John Wiley & Sons, Ltd. This work was proposed to address two key issues that hinder the quality by design implementation of herbal drugs. The first is the quality variation of herbal raw materials and the second is the difficulty in defining the acceptable ranges of critical quality attributes (CQAs). Accordingly, a feedforward control strategy and a method for defining the acceptable ranges of CQAs were proposed. A case study of the ethanol precipitation process was conducted to show the applicability of the methodology.

Considerations on Regulatory Quality Control in Pharmaceutical Industry

Quality by Design in Pharmaceuticals: A Review of its Impact on Regulatory Compliance and Product Quality

Consideration and Exploration Upon the Effective Quality Control over Medical Links

State of Art in Quality Control Systems of Polymer Production Processes

Quality management by means of comments on prescriptions in the hospital

US FDA's Regulatory System for Drug Manufacturing Quality

Implementation of Quality by Design in the Program of Safety Re-evaluation of TCM Injections

Quality-by-design in pharmaceutical development: From current perspectives to practical applications

[Quality control strategy of traditional Chinese medicine based on pharmaceutical product lifecycle management].

Pharmaceutical product development: A quality by design (QbD) approach

Research advances in secondary development of Chinese patentmedicines based on quality by design concept

Quality By Design (QbD): A Comprehensive Understanding and Implementation In Pharmaceuticals Development

[A Strategy of Constructing the Technological System for Quality Control of Chinese Medicine Based on Process Control and Management].

Advancing herbal medicine: enhancing product quality and safety through robust quality control practices

Quality by Design Approach: Progress in Pharmaceutical method Development and Validation

Quality by design for herbal drugs: a feedforward control strategy and an approach to define the acceptable ranges of critical quality attributes.

Pharmaceutical Quality by Design: Product and Process Development, Understanding, and Control

Quality by design (QbD) approaches in current pharmaceutical set-up

Research progress on feedforward control strategy and its application prospect in quality control of Chinese materia medica

An Overview on Quality by Design

Pharmaceutical product development: A quality by design approach